TSXV:PSYB.H - Post Discussion
Post by
Betteryear2 on Jul 21, 2023 10:37am
Awarded Approval to Manufacture Biosynthetic Tryptamines
Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon discovery and development of novel, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, today announces that it has received government sanctioned, formal written approval to manufacture PsyBio's proprietary biosynthetic tryptamines. PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale (newsfilecorp.com)
Be the first to comment on this post